X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
france (8) 8
health economics (7) 7
index medicus (7) 7
medicine & public health (7) 7
pharmacoeconomics and health outcomes (7) 7
public health (7) 7
cost analysis (6) 6
drugs (6) 6
economics (6) 6
health administration (6) 6
health care sciences & services (6) 6
health policy & services (6) 6
pharmacology & pharmacy (6) 6
quality of life research (6) 6
clinical trials (5) 5
decision making (5) 5
economics and finance (5) 5
humanities and social sciences (5) 5
studies (5) 5
[ shs.eco ] humanities and social sciences/economies and finances (4) 4
budget impact analysis (4) 4
drug therapy (4) 4
female (4) 4
health technology assessment (4) 4
male (4) 4
adolescent (3) 3
adult (3) 3
african trypanosomiasis (3) 3
angola (3) 3
animals (3) 3
budgets (3) 3
clinical medicine (3) 3
cost-benefit analysis (3) 3
drug therapy, combination (3) 3
efficacy (3) 3
eflornithine - adverse effects (3) 3
french authority for health (3) 3
health expenditure (3) 3
health interventions (3) 3
infectious diseases (3) 3
medical device industry (3) 3
medical equipment (3) 3
methodological guidelines (3) 3
middle aged (3) 3
nifurtimox - adverse effects (3) 3
pharmacoeconomics (3) 3
research article (3) 3
schedule (3) 3
technology assessment, biomedical - methods (3) 3
trypanocidal agents - adverse effects (3) 3
trypanosomiasis, african - drug therapy (3) 3
[shs.eco]humanities and social sciences/economies and finances (2) 2
aged (2) 2
alpha-difluoromethylornithine (2) 2
analyse d’impact budgétaire (2) 2
analysis (2) 2
child (2) 2
child, preschool (2) 2
congo (2) 2
cost-effectiveness (2) 2
disease (2) 2
dk/atira/pure/core/subjects/health (2) 2
dosage and administration (2) 2
dépenses de santé (2) 2
eflornithine (2) 2
eflornithine - administration & dosage (2) 2
eflornithine - therapeutic use (2) 2
europe (2) 2
guide méthodologique (2) 2
guidelines as topic (2) 2
haute autorité de santé (2) 2
health (2) 2
health care policy (2) 2
health sciences (2) 2
human african trypanosomiasis (2) 2
immunology (2) 2
impact analysis (2) 2
interventions de santé (2) 2
klinisk medicin (2) 2
literature reviews (2) 2
medical economics (2) 2
medical technology (2) 2
medicine (2) 2
melarsoprol treatment (2) 2
metabolism (2) 2
methods (2) 2
microbiology (2) 2
nifurtimox (2) 2
nifurtimox - administration & dosage (2) 2
nifurtimox - therapeutic use (2) 2
nonsteroidal anti-inflammatory drugs (2) 2
parasitology (2) 2
patients (2) 2
pharmaceutical industry (2) 2
public health and epidemiology (2) 2
public, environmental & occupational health (2) 2
rheumatology (2) 2
risk-factors (2) 2
safety (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9683, pp. 56 - 64
Journal Article
PharmacoEconomics, ISSN 1170-7690, 01/2019, Volume 37, Issue 1, pp. 1 - 6
Models have become a nearly essential component of health technology assessment. This is because the efficacy and safety data available from clinical trials... 
DECISION-ANALYTIC MODELS | HEALTH CARE SCIENCES & SERVICES | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | NATIONAL-INSTITUTE | ECONOMICS | HEALTH
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2007, Volume 45, Issue 11, pp. 1435 - 1442
Journal Article
Journal Article
Expert Review of Pharmacoeconomics and Outcomes Research, ISSN 1473-7167, 09/2017, Volume 17, Issue 5, pp. 489 - 494
Background: Our aim was to review the selection and methods used for deriving health state utility (HSU) estimates included in the cost-utility analyses (CUA)... 
health-state utility | health-related quality of life | France | quality-adjusted life-years | Economic evaluation | COST-EFFECTIVENESS | QALYS | MODELS | HEALTH CARE SCIENCES & SERVICES | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | VALUES
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 11/2012, Volume 6, Issue 11, p. e1920
Journal Article
International Journal of Technology Assessment in Health Care, ISSN 0266-4623, 2017, Volume 33, Issue S1, pp. 55 - 55
INTRODUCTION:Budget impact analysis (BIA) provides short and medium-term estimated effect of new health interventions on budgets and resources. Since January... 
Health care | Drugs | Economics | Transparency | Federal budgets | Health | Standardization | Exploration | Impact analysis | Literature reviews | Consultation | Technology assessment | Documents | Cost analysis
Journal Article
SANTE PUBLIQUE, ISSN 0995-3914, 07/2017, Volume 29, Issue 4, pp. 585 - 588
Introduction: Budget impact analysis (BIA) provides short and medium-term estimates on changes in budgets and resources resulting from the adoption of new... 
Methodological guidelines | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | Health expenditure | French authority for health | Health interventions | Budget impact analysis | France | Decision Making | Government Agencies | Guidelines as Topic | Budgets | Humans
Journal Article
PharmacoEconomics, 01/2019, Volume 37, Issue 1, p. 1
Models have become a nearly essential component of health technology assessment. This is because the efficacy and safety data available from clinical trials... 
Journal Article
PharmacoEconomics, 04/2018, Volume 36, Issue 4, p. 407
Budget impact analysis (BIA) provides short- and medium-term estimates on changes in budgets and health outcomes resulting from the adoption of new health... 
Journal Article
Santé Publique, ISSN 0995-3914, 2017, Volume 29, Issue 4, pp. 585 - 588
Introduction : L'analyse d'impact budgétaire (AIB) est une approche économique destinée à estimer, sur un horizon temporel à court et à moyen terme, les... 
Journal Article
Expert review of pharmacoeconomics & outcomes research, 10/2017, Volume 17, Issue 5, p. 489
Our aim was to review the selection and methods used for deriving health state utility (HSU) estimates included in the cost-utility analyses (CUA) submitted by... 
Quality-Adjusted Life Years | Technology Assessment, Biomedical - methods | Costs and Cost Analysis | Technology Assessment, Biomedical - economics | Cost-Benefit Analysis | Drug Industry - economics | Humans | France | Health Status
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.